|
[1]
|
Gong, L.J., Wang, X.Y., Yao, X., Wu, X. and Gu, W.Y. (2021) CircESRP1 Inhibits Clear Cell Renal Cell Carcinoma Progression through the CTCF-Mediated Positive Feedback Loop. Cell Death & Disease, 12, Article No. 1081. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Parosanu, A.I., Nititpir, C., Stanciu, I.M. and Baston, C. (2025) Early-Stage Renal Cell Carcinoma: Who Needs Adjuvant Therapy? Biomedicines, 13, Article 543. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Krause, F., Stoffel, M., Winterhagen, F.I., Ellinger, J., Kristiansen, G., Ritter, M., et al. (2025) Reticulocalbin-1 in Clear Cell Renal Cell Carcinoma: Clinical and Functional Evidence for Its Role as a Biomarker and Potential Therapeutic Target. BMC Cancer, 25, Article No. 1425. [Google Scholar] [CrossRef]
|
|
[4]
|
Masson, C., Thouvenin, J., Boudier, P., Maillet, D., Kuchler-Bopp, S., Barthélémy, P., et al. (2023) Biological Biomarkers of Response and Resistance to Immune Checkpoint Inhibitors in Renal Cell Carcinoma. Cancers, 15, Article No. 3159. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Gao, J., Ye, F., Han, F., Wang, X., Jiang, H. and Zhang, J. (2021) A Novel Radiogenomics Biomarker Based on Hypoxic-Gene Subset: Accurate Survival and Prognostic Prediction of Renal Clear Cell Carcinoma. Frontiers in Oncology, 11, Article 739815. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Lin, E., Liu, X., Liu, Y., Zhang, Z., Xie, L., Tian, K., et al. (2021) Roles of the Dynamic Tumor Immune Microenvironment in the Individualized Treatment of Advanced Clear Cell Renal Cell Carcinoma. Frontiers in Immunology, 12, Article 653358. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Zhang, X., Sun, Y., Ma, Y., Gao, C., Zhang, Y., Yang, X., et al. (2023) Tumor-Associated M2 Macrophages in the Immune Microenvironment Influence the Progression of Renal Clear Cell Carcinoma by Regulating M2 Macrophage-Associated Genes. Frontiers in Oncology, 13, Article 1157861. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Xie, Y., Tang, G., Xie, P., Zhao, X., Chen, C., Li, X., et al. (2024) High CD204+ Tumor-Associated Macrophage Density Predicts a Poor Prognosis in Patients with Clear Cell Renal Cell Carcinoma. Journal of Cancer, 15, 1511-1522. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Xie, Y., Chen, Z., Zhong, Q., Zheng, Z., Chen, Y., Shangguan, W., et al. (2021) M2 Macrophages Secrete CXCL13 to Promote Renal Cell Carcinoma Migration, Invasion, and EMT. Cancer Cell International, 21, Article No. 677. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Xu, Y., Li, L., Yang, W., Zhang, K., Zhang, Z., Yu, C., et al. (2023) TRAF2 Promotes M2-Polarized Tumor-Associated Macrophage Infiltration, Angiogenesis and Cancer Progression by Inhibiting Autophagy in Clear Cell Renal Cell Carcinoma. Journal of Experimental & Clinical Cancer Research, 42, Article No. 159. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Hua, X., Chen, J., Su, Y. and Liang, C. (2020) Identification of an Immune-Related Risk Signature for Predicting Prognosis in Clear Cell Renal Cell Carcinoma. Aging, 12, 2302-2332. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Tomczak, K., Czerwińska, P. and Wiznerowicz, M. (2015) The Cancer Genome Atlas (TCGA): An Immeasurable Source of Knowledge. Współczesna Onkologia, 1, 68-77. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Clough, E., Barrett, T., Wilhite, S.E., Ledoux, P., Evangelista, C., Kim, I.F., et al. (2024) NCBI GEO: Archive for Gene Expression and Epigenomics Data Sets: 23-Year Update. Nucleic Acids Research, 52, D138-D144. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Langfelder, P. and Horvath, S. (2008) WGCNA: An R Package for Weighted Correlation Network Analysis. BMC Bioinformatics, 9, Article No. 559. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
The Gene Ontology Consortium, Carbon, S., Douglass, E., Good, B.M., Unni, D.R., et al. (2021) The Gene Ontology Resource: Enriching a Gold Mine. Nucleic Acids Research, 49, D325-D334.
|
|
[16]
|
Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. and Ishiguro-Watanabe, M. (2022) KEGG for Taxonomy-Based Analysis of Pathways and Genomes. Nucleic Acids Research, 51, D587-D592. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Tang, Z., Li, C., Kang, B., Gao, G., Li, C. and Zhang, Z. (2017) GEPIA: A Web Server for Cancer and Normal Gene Expression Profiling and Interactive Analyses. Nucleic Acids Research, 45, W98-W102. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Hänzelmann, S., Castelo, R. and Guinney, J. (2013) GSVA: Gene Set Variation Analysis for Microarray and RNA-Seq Data. BMC Bioinformatics, 14, Article No. 7. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Grigolo, S. and Filgueira, L. (2024) Immunotherapy of Clear-Cell Renal-Cell Carcinoma. Cancers, 16, Article No. 2092. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Petitprez, F., Ayadi, M., de Reyniès, A., Fridman, W.H., Sautès-Fridman, C. and Job, S. (2021) Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma. Frontiers in Oncology, 11, Article 643065.
|
|
[21]
|
Shapiro, D.D., Lozar, T., Cheng, L., Xie, E., Laklouk, I., Lee, M.H., et al. (2024) Non-Metastatic Clear Cell Renal Cell Carcinoma Immune Cell Infiltration Heterogeneity and Prognostic Ability in Patients Following Surgery. Cancers, 16, Article No. 478. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Zhang, Z. and Zhan, F. (2023) Type 2 Cystatins and Their Roles in the Regulation of Human Immune Response and Cancer Progression. Cancers, 15, Article No. 5363. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Huang, D., Li, J., He, Z., Liang, W., Zhong, L., Huang, J., et al. (2025) Pan-Cancer and Experimental Analyses Reveal the Immunotherapeutic Significance of CST2 and Its Association with Stomach Adenocarcinoma Proliferation and Metastasis. Frontiers in Immunology, 15, Article 1466806. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Bao, Y., Wang, L., Shi, L., Yun, F., Liu, X., Chen, Y., et al. (2019) Transcriptome Profiling Revealed Multiple Genes and ECM-Receptor Interaction Pathways That May Be Associated with Breast Cancer. Cellular & Molecular Biology Letters, 24, Article No. 38. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Karalis, T. (2023) Targeting Hyaluronan Synthesis in Cancer: A Road Less Travelled. Biologics, 3, 402-414. [Google Scholar] [CrossRef]
|
|
[26]
|
Cirillo, N. (2023) The Hyaluronan/CD44 Axis: A Double-Edged Sword in Cancer. International Journal of Molecular Sciences, 24, Article 15812. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Jokelainen, O., Pasonen-Seppänen, S., Tammi, M., Mannermaa, A., Aaltomaa, S., Sironen, R., et al. (2020) Cellular Hyaluronan Is Associated with a Poor Prognosis in Renal Cell Carcinoma. Urologic Oncology: Seminars and Original Investigations, 38, 686.e11-686.e22. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Janowska, J.D. (2020) C1q/TNF-Related Protein 1, a Multifunctional Adipokine: An Overview of Current Data. The American Journal of the Medical Sciences, 360, 222-228. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Qiu, J., Wang, Z., Zhao, L., Zhang, P., Xu, Y. and Xia, Q. (2023) High C1QTNF1 Expression Mediated by Potential ncRNAs Is Associated with Poor Prognosis and Tumor Immunity in Kidney Renal Clear Cell Carcinoma. Frontiers in Molecular Biosciences, 10, Article 1201155. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Chen, W., Lin, W., Wu, L., Xu, A., Liu, C. and Huang, P. (2022) A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma Based on Necroptosis-Related Gene Signature. International Journal of Medical Sciences, 19, 377-392. [Google Scholar] [CrossRef] [PubMed]
|